Treatment of germ cell tumors – update 2006
- 1 September 2006
- journal article
- review article
- Published by Elsevier in Annals of Oncology
- Vol. 17 (suppl_10) , x31-x35
- https://doi.org/10.1093/annonc/mdl232
Abstract
1Division of Medical Oncology, British Columbia Cancer Agency-Vancouver Cancer Centre, Vancouver, Canada; 2Department of Medical Oncology, Hematology, Pneumology, and Bone Marrow Transplantation, University Medical Center Eppendorf, Hamburg, GermanyKeywords
This publication has 47 references indexed in Scilit:
- Etoposide and Cisplatin Chemotherapy for Metastatic Good-Risk Germ Cell TumorsJournal of Clinical Oncology, 2005
- Curing metastatic cancer: lessons from testicular germ-cell tumoursNature Reviews Cancer, 2003
- Identification of Genes That Mediate Sensitivity to CisplatinMolecular Pharmacology, 2001
- Lung resistance-related protein/major vault protein and vaults in multidrug-resistant cancerCurrent Opinion in Oncology, 2000
- A Family of Drug Transporters: the Multidrug Resistance-Associated ProteinsJNCI Journal of the National Cancer Institute, 2000
- Defective repair of cisplatin-induced DNA damage caused by reduced XPA protein in testicular germ cell tumoursCurrent Biology, 1999
- DNA Repair capacity and cisplatin sensitivity of human testis tumour cellsInternational Journal of Cancer, 1997
- International Germ Cell Consensus Classification: a prognostic factor-based staging system for metastatic germ cell cancers. International Germ Cell Cancer Collaborative Group.Journal of Clinical Oncology, 1997
- DNA Repair in Cisplatin-Sensitive and Resistant Human Cell Lines Measured in Specific Genes by Quantitative Polymerase Chain ReactionBiochemical Pharmacology, 1996
- Cellular basis for differential sensitivity to cisplatin in human germ cell tumour and colon carcinoma cell linesBritish Journal of Cancer, 1995